DE-126 ophthalmic solution

· Santen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-126 ophthalmic solution, covering 2020-10-23 to 2020-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study [Phase 2]

See pricing